Pharmacists in Ferguson, MO Accepting Medicare

6 Pharmacists found. Showing 1 - 6

David Neil Gremaud, R PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 190 N Florissant Rd, Ferguson, MO 63135 Phone: 314-521-4518    Fax: 314-522-6214

Matthew Ruiz Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 190 N Florissant Rd, Ferguson, MO 63135 Phone: 314-521-4518

Mr. Larry Donnell Perkins, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 49 N Florissant Rd, Ferguson, MO 63135 Phone: 314-521-1071

Sarah Fox, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 49 N Florissant Rd, Ferguson, MO 63135 Phone: 314-524-4144

Mrs. Kimberly Michelle Ragland, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 49 N Florissant Rd, Ferguson, MO 63135 Phone: 314-524-4144    Fax: 314-524-8650

Adam Carey Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 190 N Florissant Rd, Ferguson, MO 63135 Phone: 314-521-4518

News Archive

Caltech researchers identify gene that causes severe insomnia when overactivated

Caltech biologists have performed the first large-scale screening in a vertebrate animal for genes that regulate sleep, and have identified a gene that when overactivated causes severe insomnia. Expression of the gene, neuromedin U (Nmu), also seems to serve as nature's stimulant-fish lacking the gene take longer to wake up in the morning and are less active during the day.

Study uses machine learning and health data to identify suicide risk factors

First-of-its-kind study used machine learning and health data from the entire Danish population to create sex-specific suicide risk profiles, illuminating the complex mix of factors that may predict suicide.

Ultrasound strategy excludes DVT in pregnant women

Serial compression ultrasonography with iliac vein visualization can reliably exclude deep vein thrombosis in symptomatic pregnant women, according to results from an 8-year prospective cohort study published in the Canadian Medical Association Journal.

Study reveals how the properties of embryonic stem cells are controlled

Scientists have made a fundamental discovery about how the properties of embryonic stem cells are controlled.

PanOptica doses first patient in Phase 1/2 dose-ranging clinical trial of PAN-90806

PanOptica, Inc., a private biopharmaceutical company focused on developing innovative ophthalmology therapies, today announced that the Company has dosed the first patient in a Phase 1/2 dose-ranging clinical trial of PAN-90806, a once-daily topical eye drop formulation of a small-molecule anti-vascular endothelial growth factor (anti-VEGF) for the treatment of neovascular eye diseases.

Read more Medical News

› Verified 5 days ago